| Theme | Chemotherapy for Gastrointestinal Malignancy | |
|---|---|---|
| Title | Tumor Dormancy by Anti-Angiogenesis | |
| Publish Date | 2001/05 | |
| Author | Yutaka Takahashi | Department of Surgical Oncology, Cancer Research Institute, Kanazawa University |
| Author | Masayoshi Mai | Department of Surgical Oncology, Cancer Research Institute, Kanazawa University |
| [ Summary ] | Clinical trials of anti-angiogenetic drugs, such as anti vascular endothelial cell growth factor (VEGF) antibody, inhibitor of VEGF receptor tyrosine kinase, are in phase II/III studies in the United States and Europe. In this paper, we introduced data concerning these drugs in relation to colorectal cancer and discussed strategies related to anti-angiogenesis, not associated with tumor atrophy, but to tumor dormancy. | |